Return to home page
The Pharmaceutical Journal Vol 263 No 7067 p655
October 16, 1999 Products

Prescription products

Distribution change

The product licence for Migril tablets has been transferred from Glaxo Wellcome to CP Pharmaceuticals. CP is now also responsible for the sales, marketing and distribution of the product. All orders and inquiries should now be addressed to CP Pharmaceuticals Ltd, Ash Road North, Wrexham Industrial Estate, Wrexham LL13 9UF (tel 01978 661261, fax 01978 660130).